Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Horsburgh

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 4, 2019
Discordant rifampicin susceptibility results are associated with Xpert<sup>®</sup> MTB/RIF probe B and probe binding delayR H Berhanu, K Schnippel, R Kularatne, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 12, 2018
Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia?R H Berhanu, K Schnippel, R Kularatne, et al.
The Journal of Clinical Investigation|September 1, 1984
Fibronectin deposition in delayed-type hypersensitivity. Reactions of normals and a patient with afibrinogenemiaR A Clark, C R Horsburgh, A A Hoffman, et al.
Journal of Clinical Immunology|January 1, 1986
Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III)C R Horsburgh, K C Davis, U Hasiba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 6, 2012
Compassionate use of and expanded access to new drugs for drug-resistant tuberculosisC R Horsburgh, M Haxaire-Theeuwes, C Lienhardt, et al.
The American Review of Respiratory Disease|September 11, 1991
Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapyC R Horsburgh, J A Havlik, D A Ellis, et al.
IJTLD Open|June 17, 2026
Scoping review of community-wide screening to break the chain of TB transmissionC R Horsburgh, H E Jenkins, E A Kendall, et al.
The Journal of Infectious Diseases|February 1, 1991
Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?R F Khabbaz, D Hartel, M Lairmore, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndromeC R Horsburgh, D L Cohn, R B Roberts, et al.
The Journal of Infectious Diseases|March 14, 1998
Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosisC F von Reyn, D E Williams, C R Horsburgh, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 4, 2019
Discordant rifampicin susceptibility results are associated with Xpert<sup>®</sup> MTB/RIF probe B and probe binding delayR H Berhanu, K Schnippel, R Kularatne, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 12, 2018
Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia?R H Berhanu, K Schnippel, R Kularatne, et al.
The Journal of Clinical Investigation|September 1, 1984
Fibronectin deposition in delayed-type hypersensitivity. Reactions of normals and a patient with afibrinogenemiaR A Clark, C R Horsburgh, A A Hoffman, et al.
Journal of Clinical Immunology|January 1, 1986
Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III)C R Horsburgh, K C Davis, U Hasiba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 6, 2012
Compassionate use of and expanded access to new drugs for drug-resistant tuberculosisC R Horsburgh, M Haxaire-Theeuwes, C Lienhardt, et al.
The American Review of Respiratory Disease|September 11, 1991
Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapyC R Horsburgh, J A Havlik, D A Ellis, et al.
IJTLD Open|June 17, 2026
Scoping review of community-wide screening to break the chain of TB transmissionC R Horsburgh, H E Jenkins, E A Kendall, et al.
The Journal of Infectious Diseases|February 1, 1991
Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?R F Khabbaz, D Hartel, M Lairmore, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndromeC R Horsburgh, D L Cohn, R B Roberts, et al.
The Journal of Infectious Diseases|March 14, 1998
Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosisC F von Reyn, D E Williams, C R Horsburgh, et al.
Pageof 12